MGNX

MacroGenics, Inc. News Headlines

$21.31
*  
0.03
0.14%
Get MGNX Alerts
*Delayed - data as of Sep. 17, 2014  -  Find a broker to begin trading MGNX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

MacroGenics: A Late Stage Pipeline Review
8/29/2014 8:00:00 PM - Seeking Alpha

ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners
7/25/2014 10:52:00 AM - Seeking Alpha

CLSN's Dignity At Work, GSK's Flonase To Go OTC, MGNX Hits Second Dart
7/25/2014 12:52:00 AM - RTT News

Gilead's Pipeline Requires MacroGenics' ImmunoOncology Platform (M&A)
7/22/2014 3:20:00 PM - Seeking Alpha

MacroGenics: A Balanced Small Cap Bio With A Great Entry Level Opportunity
6/11/2014 9:59:00 AM - Seeking Alpha

MacroGenics (MGNX) Worth Watching: Stock Up 5.1% - Tale of the Tape
5/30/2014 9:25:00 AM - Zacks.com

Weekly 3-Year Low Highlights: KN, MGNX, MIXT, EDMC
5/27/2014 1:32:09 PM - GuruFocus

MacroGenics (MGNX) Jumps: Stock Up 7.5% - Tale of the Tape
4/24/2014 9:39:01 AM - Zacks.com

Cohen’s Point72 Asset Management buys a stake in MacroGenics
4/18/2014 9:00:00 AM - Market Realist

Salesforce (CRM) & MacroGenics (MGNX): The Relative Value of Potential
3/10/2014 11:23:53 AM - Martin Tillier

MacroGenics - Good Pipeline, Stretched Valuation
3/5/2014 12:32:00 PM - Seeking Alpha

Combination Therapies: Where Immuno-Oncology Is Headed And How To Invest
2/6/2014 8:55:00 AM - Seeking Alpha

Healthcare Stocks Little Changed Ahead of Bell; MacroGenics Releases Data on Potential Leukemia Treatment
12/9/2013 4:57:09 PM - MT Newswires

Sector Update: Healthcare
12/9/2013 4:56:37 PM - MT Newswires

U.S. IPO Recap: Antero Completes $1.6 Billion IPO, 13 Companies File
10/14/2013 10:51:00 AM - Seeking Alpha

4 U.S. IPOs Planned For The Week Of Oct. 14
10/14/2013 10:35:00 AM - Seeking Alpha

US IPO Recap: Antero completes $1.6 billion IPO, 13 companies file
10/14/2013 9:04:56 AM - Renaissance Capital

4 US IPOs planned for the week of Oct 14
10/14/2013 7:57:23 AM - Renaissance Capital

MacroGenics - Cancer IPOs Remain The Hottest Thing In Town
10/14/2013 5:27:00 AM - Seeking Alpha

CLOSING UPDATE: GOP Proposal to Avert Default Triggers Massive Short-Covering Rally
10/10/2013 4:05:43 PM - MT Newswires

Stock Market Soars as Investors Bet on Deal to Raise Debt Ceiling
10/10/2013 4:00:51 PM - MT Newswires

MacroGenics: Big Dreams, Good Molecules
10/10/2013 9:28:00 AM - Seeking Alpha

MacroGenics prices IPO at $16, the high end of the original range
10/9/2013 7:15:53 PM - Renaissance Capital

IPO Preview: MacroGenics
10/9/2013 5:39:00 PM - Seeking Alpha

MacroGenics increases shares offered and raises price to $16, the high end of the range
10/9/2013 9:11:36 AM - Renaissance Capital